{"id":"https://openalex.org/W2139507494","doi":"https://doi.org/10.1128/aac.00780-12","title":"Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients","display_name":"Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients","publication_year":2012,"publication_date":"2012-08-07","ids":{"openalex":"https://openalex.org/W2139507494","doi":"https://doi.org/10.1128/aac.00780-12","mag":"2139507494","pmid":"https://pubmed.ncbi.nlm.nih.gov/22869562","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3457362"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00780-12","doi":"https://doi.org/10.1128/aac.00780-12","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00780-12","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3457362","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027618515","display_name":"Hadas Dvory\u2010Sobol","orcid":"https://orcid.org/0000-0003-0716-2750","observed_orcids":["https://orcid.org/0000-0003-0716-2750"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hadas Dvory-Sobol","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052153110","display_name":"Kelly A. Wong","orcid":"https://orcid.org/0009-0003-4959-8787","observed_orcids":["https://orcid.org/0009-0003-4959-8787"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly A. Wong","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA","aGilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"aGilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110241747","display_name":"Karin S. Ku","orcid":"https://orcid.org/0000-0001-7695-3332","observed_orcids":["https://orcid.org/0000-0001-7695-3332"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karin S. Ku","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA","aGilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"aGilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011497551","display_name":"Andrew S. Bae","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Bae","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA","aGilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"aGilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075322332","display_name":"Eric Lawitz","orcid":"https://orcid.org/0000-0002-4234-224X","observed_orcids":["https://orcid.org/0000-0002-4234-224X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric J. Lawitz","raw_affiliation_strings":["Alamo Medical Research, San Antonio, Texas, USA","bAlamo Medical Research, San Antonio, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alamo Medical Research, San Antonio, Texas, USA","institution_ids":[]},{"raw_affiliation_string":"bAlamo Medical Research, San Antonio, Texas, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034653499","display_name":"Phillip S. Pang","orcid":"https://orcid.org/0000-0002-8811-9801","observed_orcids":["https://orcid.org/0000-0002-8811-9801"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip S. Pang","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA","aGilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"aGilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001293746","display_name":"Jeanette L. Harris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeanette Harris","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA","aGilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"aGilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107967845","display_name":"Michael D. Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D. Miller","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA","aGilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"aGilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000831108","display_name":"Hongmei Mo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongmei Mo","raw_affiliation_strings":["Gilead Sciences, Foster City, California, USA","aGilead Sciences, Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"aGilead Sciences, Foster City, California, USA","institution_ids":["https://openalex.org/I4210140816"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2169,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.92083174,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"56","issue":"10","first_page":"5289","last_page":"5295"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.7269999980926514},{"id":"https://openalex.org/keywords/ns3-4a-protease-inhibitors","display_name":"NS3/4A protease inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8040000200271606},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.9089999794960022},{"id":"https://openalex.org/keywords/ns5b-inhibitors","display_name":"NS5B inhibitors","score":0.8289999961853027},{"id":"https://openalex.org/keywords/ns5a-inhibitors","display_name":"NS5A inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5180000066757202},{"id":"https://openalex.org/keywords/antiviral-monotherapy","display_name":"antiviral monotherapy","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C132379496","wikidata":"https://www.wikidata.org/wiki/Q83141645","display_name":"NS3","level":4,"score":0.8906611800193787},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7304075956344604},{"id":"https://openalex.org/C2777103181","wikidata":"https://www.wikidata.org/wiki/Q83141840","display_name":"NS5A","level":5,"score":0.7116317749023438},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.6735708713531494},{"id":"https://openalex.org/C2781426373","wikidata":"https://www.wikidata.org/wiki/Q24766653","display_name":"NS5B","level":5,"score":0.6544975638389587},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.6321402192115784},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.542062520980835},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.48030370473861694},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.46099260449409485},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4292389452457428},{"id":"https://openalex.org/C2781463415","wikidata":"https://www.wikidata.org/wiki/Q2082778","display_name":"Hepacivirus","level":4,"score":0.3596113920211792},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33720481395721436},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.09250488877296448},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.00780-12","doi":"https://doi.org/10.1128/aac.00780-12","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00780-12","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2611894","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3457362","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3457362","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3457362","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:22869562","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22869562","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2611894","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3457362","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7900000214576721,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W138424127","https://openalex.org/W1979174109","https://openalex.org/W1983906683","https://openalex.org/W1995565071","https://openalex.org/W1995704702","https://openalex.org/W2001129358","https://openalex.org/W2004700137","https://openalex.org/W2011616459","https://openalex.org/W2012503063","https://openalex.org/W2023926449","https://openalex.org/W2027545702","https://openalex.org/W2043976325","https://openalex.org/W2046533694","https://openalex.org/W2047208492","https://openalex.org/W2057468244","https://openalex.org/W2062749605","https://openalex.org/W2064546869","https://openalex.org/W2072655657","https://openalex.org/W2100844926","https://openalex.org/W2107713887","https://openalex.org/W2127685726","https://openalex.org/W2151898297","https://openalex.org/W2159835094","https://openalex.org/W2163145108","https://openalex.org/W2314619766","https://openalex.org/W4246639567"],"related_works":["https://openalex.org/W2047424287","https://openalex.org/W2320932054","https://openalex.org/W2580272512","https://openalex.org/W2523672505","https://openalex.org/W2182684293","https://openalex.org/W7096343524","https://openalex.org/W2123343552","https://openalex.org/W2024726373","https://openalex.org/W2624529232","https://openalex.org/W2163145108"],"abstract_inverted_index":{"GS-9451,":[0,142,158],"a":[1,44,97],"novel":[2],"hepatitis":[3],"C":[4],"virus":[5],"(HCV)":[6],"nonstructural":[7],"3/4a":[8],"(NS3/4a)":[9],"protease":[10,70],"inhibitor,":[11],"is":[12,29],"highly":[13],"active":[14],"in":[15,38,43,113,120,161,179,203],"patients":[16,42,123,133,206],"infected":[17],"with":[18,75,125,144,163,172],"HCV":[19,92,239],"genotype":[20],"1":[21,40],"(GT":[22],"1).":[23],"The":[24,50,229],"aim":[25],"of":[26,36,115,128,141,205,231,238,244],"this":[27],"study":[28],"to":[30,88,157,216],"characterize":[31],"the":[32,60,116,200,242],"clinical":[33,212],"resistance":[34,102,156],"profile":[35],"GS-9451":[37,89,129,234],"GT":[39,164,167,181,192],"HCV-infected":[41],"phase":[45],"1,":[46],"3-day":[47],"monotherapy":[48],"study.":[49],"full-length":[51],"NS3/4A":[52],"gene":[53],"was":[54],"population":[55],"sequenced":[56],"at":[57,65,104,146,184,207],"baseline,":[58],"on":[59],"final":[61],"treatment":[62],"day,":[63],"and":[64,85,90,138,150,166,187,218,227,235],"follow-up":[66],"time":[67,189],"points.":[68,190],"NS3":[69,82,105,211],"domains":[71],"from":[72,122],"patient":[73,183],"isolates":[74],"emerging":[76],"mutations":[77,103,145,174],"were":[78,94,111,159,175,197,214],"cloned":[79],"into":[80],"an":[81],"shuttle":[83],"vector,":[84],"their":[86],"susceptibilities":[87],"other":[91,236],"inhibitors":[93,240],"determined":[95],"using":[96],"transient":[98],"replication":[99],"assay.":[100],"No":[101],"position":[106,147],"155,":[107],"156,":[108],"or":[109,119],"168":[110],"detected":[112,160,178],"any":[114,180],"baseline":[117],"samples":[118],"viruses":[121,143],"treated":[124],"60":[126],"mg":[127,137,140],"once":[130],"daily.":[131],"Among":[132],"who":[134],"received":[135],"200":[136],"400":[139],"D168":[148,173],"(D168E/G/V)":[149],"R155":[151],"(R155K),":[152],"which":[153],"confer":[154],"high-level":[155],"those":[162],"1b":[165,182],"1a":[168,193],"virus,":[169],"respectively.":[170],"Viruses":[171],"no":[176],"longer":[177],"day":[185],"14":[186],"subsequent":[188],"In":[191],"patients,":[194],"R155K":[195],"mutants":[196,213],"replaced":[198],"by":[199],"wild":[201],"type":[202],"57%":[204],"week":[208],"24.":[209],"These":[210],"sensitive":[215],"NS5B":[217],"NS5A":[219],"inhibitors,":[220],"as":[221,223],"well":[222],"alpha":[224],"interferon":[225],"(IFN-\u03b1)":[226],"ribavirin.":[228],"lack":[230],"cross-resistance":[232],"between":[233],"classes":[237],"supports":[241],"utility":[243],"combination":[245],"therapy.":[246]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}